Feature image

What's New

Agenda for the 64th meeting of the Medicines Classification Committee

Following publication of the agenda, there is a six week consultation period which provides an opportunity for interested parties to comment on agenda items. The deadline for submitting feedback is 20 March 2020.

For information on how to comment on agenda items

News and Events

Date Type Title
25/02/2020VacanciesAdvisor, Pharmacovigilance | Wellington
14/02/2020Dear Healthcare Professional LetterNozinan (Swiss Stock) (PDF 299 KB, 2 pages) Change in supply of Nozinan (levomepromazine) tablets to product sourced from Switzerland - information for healthcare professionals
12/02/2020DatasheetNozinan Tablet Swiss stock (pdf 292KB)
8/02/2020ConsultationSurvey for consumers on reporting side effects to medicines closes on 24 April 2020
7/02/2020Dear Healthcare Professional Letter Nozinan (Swiss Stock) (PDF 233 KB, 1 page) Change in supply of Nozinan (levomepromazine) tablets to product sourced from Switzerland - information for patients
7/02/2020CommitteesAgenda for the 64th Medicines Classification Committee meeting
23/01/2020Monitoring CommunicationUpdate - Everet (levetiracetam) - supply and potential seizure control issues for patients
23/01/2020Monitoring CommunicationUpdate - Dolutegravir and the possible risk of neural tube defects when taken early in pregnancy
23/01/2020CommitteesMinutes of the Medicines Adverse Reactions Committee Meeting held on 5 December 2019
8/01/2020Monitoring CommunicationM² Logo Update - Risk of infections with Prolia (denosumab)
8/01/2020Monitoring CommunicationM² Logo Update - Tramadol and opioid effects in breastfeeding babies